| William Cusick, MD | |
|
2800 Main St, Level 5, Bridgeport, CT 06606 | |
| (203) 576-6201 | |
| (203) 337-3860 |
| Full Name | William Cusick |
|---|---|
| Gender | Male |
| Speciality | Obstetrics/gynecology |
| Experience | 36 Years |
| Location | 2800 Main St, Bridgeport, Connecticut |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1447341227 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207VM0101X | Obstetrics & Gynecology - Maternal & Fetal Medicine | 033029 (Connecticut) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Hartford Healthcare Medical Group Specialists Pllc | 3173866241 | 1138 |
| Physicians For Women's Health, Llc | 3274430665 | 278 |
| Total Sono, Llc | 9739365610 | 2 |
News Archive
Spectrum Pharmaceuticals today announced that it has acquired 100% rights to RenaZorb (a family of compounds represented by SPI-014, also known as RZB-014), a lanthanum-based nanotechnology compound with potent and selective phosphate binding properties, for all human and non-human indications.
Coronavirus outbreaks have occurred periodically, but none have been as devastating as the COVID-19 pandemic.
Scientists in the USA have established a way to predict outbreaks of cholera, making it easier to control. This finding could provide a model to predict and potentially control outbreaks of other important infectious diseases.
The complexity of the brain and, more specifically, how nerve cells form billions of contacts when there are fewer than 30,000 human genes is still a scientific mystery.
› Verified 5 days ago
| Entity Name | Physicians For Women's Health, Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1801826680 PECOS PAC ID: 3274430665 Enrollment ID: O20031215000455 |
News Archive
Spectrum Pharmaceuticals today announced that it has acquired 100% rights to RenaZorb (a family of compounds represented by SPI-014, also known as RZB-014), a lanthanum-based nanotechnology compound with potent and selective phosphate binding properties, for all human and non-human indications.
Coronavirus outbreaks have occurred periodically, but none have been as devastating as the COVID-19 pandemic.
Scientists in the USA have established a way to predict outbreaks of cholera, making it easier to control. This finding could provide a model to predict and potentially control outbreaks of other important infectious diseases.
The complexity of the brain and, more specifically, how nerve cells form billions of contacts when there are fewer than 30,000 human genes is still a scientific mystery.
› Verified 5 days ago
| Entity Name | St. Vincent's Multispecialty Group Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1043544489 PECOS PAC ID: 6204977218 Enrollment ID: O20100112000538 |
News Archive
Spectrum Pharmaceuticals today announced that it has acquired 100% rights to RenaZorb (a family of compounds represented by SPI-014, also known as RZB-014), a lanthanum-based nanotechnology compound with potent and selective phosphate binding properties, for all human and non-human indications.
Coronavirus outbreaks have occurred periodically, but none have been as devastating as the COVID-19 pandemic.
Scientists in the USA have established a way to predict outbreaks of cholera, making it easier to control. This finding could provide a model to predict and potentially control outbreaks of other important infectious diseases.
The complexity of the brain and, more specifically, how nerve cells form billions of contacts when there are fewer than 30,000 human genes is still a scientific mystery.
› Verified 5 days ago
| Entity Name | Hartford Healthcare Medical Group Specialists Pllc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1023584216 PECOS PAC ID: 3173866241 Enrollment ID: O20190514001441 |
News Archive
Spectrum Pharmaceuticals today announced that it has acquired 100% rights to RenaZorb (a family of compounds represented by SPI-014, also known as RZB-014), a lanthanum-based nanotechnology compound with potent and selective phosphate binding properties, for all human and non-human indications.
Coronavirus outbreaks have occurred periodically, but none have been as devastating as the COVID-19 pandemic.
Scientists in the USA have established a way to predict outbreaks of cholera, making it easier to control. This finding could provide a model to predict and potentially control outbreaks of other important infectious diseases.
The complexity of the brain and, more specifically, how nerve cells form billions of contacts when there are fewer than 30,000 human genes is still a scientific mystery.
› Verified 5 days ago
| Mailing Address | Practice Location Address |
|---|---|
| William Cusick, MD 12 Canterbury Lane, Easton, CT 06612 Ph: (203) 459-4673 | William Cusick, MD 2800 Main St, Level 5, Bridgeport, CT 06606 Ph: (203) 576-6201 |
News Archive
Spectrum Pharmaceuticals today announced that it has acquired 100% rights to RenaZorb (a family of compounds represented by SPI-014, also known as RZB-014), a lanthanum-based nanotechnology compound with potent and selective phosphate binding properties, for all human and non-human indications.
Coronavirus outbreaks have occurred periodically, but none have been as devastating as the COVID-19 pandemic.
Scientists in the USA have established a way to predict outbreaks of cholera, making it easier to control. This finding could provide a model to predict and potentially control outbreaks of other important infectious diseases.
The complexity of the brain and, more specifically, how nerve cells form billions of contacts when there are fewer than 30,000 human genes is still a scientific mystery.
› Verified 5 days ago
Dr. Joanne Lynn Wible-kant, M.D. Obstetrics & Gynecology Medicare: Not Enrolled in Medicare Practice Location: 4749 Main St, Bridgeport, CT 06606 Phone: 203-365-4922 Fax: 203-374-2377 | |
Stephen Francis Thung, MD Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 267 Grant St Dept 8th, Bridgeport, CT 06610 Phone: 203-384-4048 | |
Ms. Djana Harp, MD Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 510 Clinton Ave, Bridgeport, CT 06605 Phone: 203-330-6000 Fax: 203-382-2954 | |
Matthew Chike Nwosu, MD Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 982 E Main St, Bridgeport, CT 06608 Phone: 203-696-3260 Fax: 203-696-3269 | |
Dr. Stevan Marjanovic, M.D. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 3180 Main St, Suite 202, Bridgeport, CT 06606 Phone: 203-374-0404 | |
Sarah Kate Leite, M.D. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 3180 Main St, Bridgeport, CT 06606 Phone: 203-374-0404 Fax: 203-372-4167 | |
Dr. Lindsay Lauren Goodman, M.D. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 267 Grant St, Bridgeport, CT 06610 Phone: 203-384-3000 |